Co-administration of aspirin and adipose-derived stem cell conditioned medium improves the functional recovery of the optic pathway in a lysolecithin-induced demyelination model

References

• Ghasemi‐Kasman M, Zare L, Baharvand H, Javan M. In vivo conversion of astrocytes to myelinating cells by miR-302/367 and valproate to enhance myelin repair. J Tissue Eng Regen Med. 2018;12(1):e462–e472. doi:10.1002/term.227628127945
   PubMed Web of Science ®Google Scholar
• Yousefi F, Ebtekar M, Soudi S, Soleimani M, Hashemi SM. In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis. Immunol Lett. 2016;172:94–105. doi:10.1016/j.imlet.2016.02.01626930038
   PubMed Web of Science ®Google Scholar
• Mondal S, Jana M, Dasarathi S, Roy A, Pahan K. Aspirin ameliorates experimental autoimmune encephalomyelitis through interleukin-11–mediated protection of regulatory T cells. Sci Signal. 2018;11(558):eaar8278. doi:10.1126/scisignal.aar827830482850
   PubMed Web of Science ®Google Scholar
• Mulakayala N, Rao P, Iqbal J, Bandichhor R, Oruganti S. Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: a brief overview. Eur J Med Chem. 2013;60:170–186. doi:10.1016/j.ejmech.2012.10.05523291119
   PubMed Web of Science ®Google Scholar
• Jadasz JJ, Kremer D, Göttle P, et al. Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturation. PLoS One. 2013;8(8):e71814. doi:10.1371/journal.pone.007181423951248
   PubMed Web of Science ®Google Scholar
• Kotter MR, Stadelmann C, Hartung H-P. Enhancing remyelination in disease—can we wrap it up? Brain. 2011;134(7):1882–1900. doi:10.1093/brain/awr01421507994
   PubMed Web of Science ®Google Scholar
• Chen J, Zuo S, Wang J, et al. Aspirin promotes oligodendrocyte precursor cell proliferation and differentiation after white matter lesion. Front Aging Neurosci. 2014;6:7. doi:10.3389/fnagi.2014.0000724478700
   PubMed Web of Science ®Google Scholar
• Zafranskaya MM, Nizheharodova DB, Yurkevich MY, et al. In vitro assessment of mesenchymal stem cells immunosuppressive potential in multiple sclerosis patients. Immunol Lett. 2013;149(1–2):9–18. doi:10.1016/j.imlet.2012.10.01023089549
   PubMed Web of Science ®Google Scholar
• Dazzi F, Krampera M. Mesenchymal stem cells and autoimmune diseases. Best Pract Res Clin Haematol. 2011;24(1):49–57. doi:10.1016/j.beha.2011.01.00221396592
   PubMed Web of Science ®Google Scholar
• Cuascut FX, Hutton GJ. Stem cell-based therapies for multiple sclerosis: current perspectives. Biomedicines. 2019;7(2):26. doi:10.3390/biomedicines7020026
   Web of Science ®Google Scholar
• Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nature Rev Immunol. 2008;8(9):726. doi:10.1038/nri239519172693
   PubMed Web of Science ®Google Scholar
• Davoodian N, Lotfi AS, Soleimani M, Mowla SJ. MicroRNA-122 overexpression promotes hepatic differentiation of human adipose tissue-derived stem cells. J Cell Biochem. 2014;115(9):1582–1593. doi:10.1002/jcb.2482224733606
   PubMed Web of Science ®Google Scholar
• Lin F. Adipose tissue–derived mesenchymal stem cells: a fat chance of curing kidney disease? Kidney Int. 2012;82(7):731–733. doi:10.1038/ki.2012.15822975993
   PubMed Web of Science ®Google Scholar
• Zuk P. Adipose-derived stem cells in tissue regeneration: a review. ISRN Stem Cells. 2013;2013:1–35.
   Google Scholar
• Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105(4):1815–1822. doi:10.1182/blood-2004-04-155915494428
   PubMed Web of Science ®Google Scholar
• Uccelli A, Benvenuto F, Laroni A, Giunti D. Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol. 2011;24(1):59–64. doi:10.1016/j.beha.2011.01.00421396593
   PubMed Web of Science ®Google Scholar
• Mammana S, Gugliandolo A, Cavalli E, et al. Human Gingival Mesenchymal Stem Cells (GMSCs) pre-treated with vesicular Moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury. J Tissue Eng Regen Med. 2019. doi:10.1002/term.2857
   Web of Science ®Google Scholar
• Rivera FJ, Couillard-Despres S, Pedre X, et al. Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells. 2006;24(10):2209–2219. doi:10.1634/stemcells.2005-061416763198
   PubMed Web of Science ®Google Scholar
• Bai L, Lennon DP, Eaton V, et al. Human bone marrow‐derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia. 2009;57(11):1192–1203. doi:10.1002/glia.2084119191336
   PubMed Web of Science ®Google Scholar
• Cantinieaux D, Quertainmont R, Blacher S, et al. Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation. PLoS One. 2013;8(8):e69515. doi:10.1371/journal.pone.006951524013448
   PubMed Web of Science ®Google Scholar
• Pawitan JA. Prospect of stem cell conditioned medium in regenerative medicine. Biomed Res Int. 2014;2014:1–14.
   Web of Science ®Google Scholar
• Noverina R, Widowati W, Ayuningtyas W, et al. Growth factors profile in conditioned medium human adipose tissue-derived mesenchymal stem cells (CM-hATMSCs). Clin Nutr Exp. 2019;24:34–44. doi:10.1016/j.yclnex.2019.01.002
   Google Scholar
• Wei X, Zhao L, Zhong J, et al. Adipose stromal cells-secreted neuroprotective media against neuronal apoptosis. Neurosci Lett. 2009;462(1):76–79. doi:10.1016/j.neulet.2009.06.05419549558
   PubMed Web of Science ®Google Scholar
• Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res. 2009;3(1):63–70. doi:10.1016/j.scr.2009.02.00619411199
   PubMed Web of Science ®Google Scholar
• Yazdi A, Khanghahi AM, Baharvand H, Javan M. Fingolimod enhances oligodendrocyte differentiation of transplanted human induced pluripotent stem cell-derived neural progenitors. Iran J Pharm Res. 2018;17(4):1444.30568702
   PubMed Web of Science ®Google Scholar
• Shaygannejad V, Janghorbani M, Ashtari F, Zakeri H. Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study. Neurol Res. 2012;34(9):854–858. doi:10.1179/1743132812Y.000000008122979982
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Benarroch E, O’Brien P, et al. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis. Neurology. 2005;64(7):1267–1269. doi:10.1212/01.WNL.0000156803.23698.9A15824361
   PubMed Web of Science ®Google Scholar
• Tsau S, Emerson MR, Lynch SG, LeVine SM. Aspirin and multiple sclerosis. BMC Med. 2015;13(1):153. doi:10.1186/s12916-015-0394-426123634
   PubMed Web of Science ®Google Scholar
• Huang N, Chen D, Wu X, et al. Aspirin promotes oligodendroglial differentiation through inhibition of Wnt signaling pathway. Mol Neurobiol. 2016;53(5):3258–3266. doi:10.1007/s12035-015-9241-z26059811
   PubMed Web of Science ®Google Scholar
• Modi KK, Sendtner M, Pahan K. Up-regulation of ciliary neurotrophic factor in astrocytes by aspirin implications for remyelination in multiple sclerosis. J Biol Chem. 2013;288(25):18533–18545. doi:10.1074/jbc.M112.44726823653362
   PubMed Web of Science ®Google Scholar
• Louis J-C, Magal E, Takayama S, Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science. 1993;259(5095):689–692. doi:10.1126/science.84303208430320
   PubMed Web of Science ®Google Scholar
• Plemel JR, Michaels NJ, Weishaupt N, et al. Mechanisms of lysophosphatidylcholine-induced demyelination: a primary lipid disrupting myelinopathy. Glia. 2018;66(2):327–347. doi:10.1002/glia.2324529068088
   PubMed Web of Science ®Google Scholar
• Sherafat MA, Javan M, Mozafari S, Mirnajafi-Zadeh J, Motamedi F. Castration attenuates myelin repair following lysolecithin induced demyelination in rat optic chiasm: an evaluation using visual evoked potential, marker genes expression and myelin staining. Neurochem Res. 2011;36(10):1887. doi:10.1007/s11064-011-0501-721626170
   PubMed Web of Science ®Google Scholar
• Baradaran S, Moghaddam AH, Ghasemi-Kasman M. Hesperetin reduces myelin damage and ameliorates glial activation in lysolecithin-induced focal demyelination model of rat optic chiasm. Life Sci. 2018;207:471–479. doi:10.1016/j.lfs.2018.07.00130056861
   PubMed Web of Science ®Google Scholar
• You Y, Gupta VK, Chitranshi N, Reedman B, Klistorner A, Graham SL. Visual evoked potential recording in a rat model of experimental optic nerve demyelination. JoVE. 2015;29(101):e52934.26273963
   PubMedGoogle Scholar
• Naeimi R, Baradaran S, Ashrafpour M, Moghadamnia AA, Ghasemi-Kasman M. Querectin improves myelin repair of optic chiasm in lyolecithin-induced focal demyelination model. Biomed Pharmacother. 2018;101:485–493. doi:10.1016/j.biopha.2018.02.12529501770
   PubMed Web of Science ®Google Scholar
• Azandaryani ZS, Davoodian N, Samiei A, Rouzbehan S. Insulin-like growth factor-I promotes hepatic differentiation of human adipose tissue-derived stem cells. Cell Biol Int. 2019;43(5):476–485.
   Web of Science ®Google Scholar
• Shimojima C, Takeuchi H, Jin S, et al. Conditioned medium from the stem cells of human exfoliated deciduous teeth ameliorates experimental autoimmune encephalomyelitis. J Immunol. 2016;196(10):4164–4171. doi:10.4049/jimmunol.150145727053763
   PubMed Web of Science ®Google Scholar
• Daneshdoust D, Khalili-Fomeshi M, Ghasemi-Kasman M, et al. Pregabalin enhances myelin repair and attenuates glial activation in lysolecithin-induced demyelination model of rat optic chiasm. Neuroscience. 2017;344:148–156. doi:10.1016/j.neuroscience.2016.12.03728049030
   PubMed Web of Science ®Google Scholar
• Hashemian M, Ghasemi-Kasman M, Parsian H, Sadeghi F. Fingolimod (FTY720) improves the functional recovery and myelin preservation of the optic pathway in focal demyelination model of rat optic chiasm. Brain Res Bull. 2019. doi:10.1016/j.brainresbull.2019.08.014
   Web of Science ®Google Scholar
• Naeimi R, Safarpour F, Hashemian M, et al. Curcumin-loaded nanoparticles ameliorate glial activation and improve myelin repair in lysolecithin-induced focal demyelination model of rat corpus callosum. Neuroscience letters. 2018;674:1-10.
   Web of Science ®Google Scholar
• Ahmadian SR, Ghasemi-Kasman M, Pouramir M, Sadeghi F. Arbutin attenuates cognitive impairment and inflammatory response in pentylenetetrazol-induced kindling model of epilepsy. Neuropharmacology. 2019;146(1):117–127.
   Web of Science ®Google Scholar
• Gol M, Ghorbanian D, Hassanzadeh S, Javan M, Mirnajafi-Zadeh J, Ghasemi-Kasman M. Fingolimod enhances myelin repair of hippocampus in pentylenetetrazol-induced kindling model. Eur J Pharm Sci. 2017;96:72–83. doi:10.1016/j.ejps.2016.09.01627634580
   PubMed Web of Science ®Google Scholar
• Akbari A, Khalili-Fomeshi M, Ashrafpour M, Moghadamnia AA, Ghasemi-Kasman M. Adenosine A2A receptor blockade attenuates spatial memory deficit and extent of demyelination areas in lyolecithin-induced demyelination model. Life Sci. 2018;205:63–72. doi:10.1016/j.lfs.2018.05.00729730168
   PubMed Web of Science ®Google Scholar
• Fancy SP, Kotter MR, Harrington EP, et al. Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol. 2010;225(1):18–23. doi:10.1016/j.expneurol.2009.12.02020044992
   PubMed Web of Science ®Google Scholar
• Huang JK, Fancy SP, Zhao C, Rowitch DH, Franklin RJ. Myelin regeneration in multiple sclerosis: targeting endogenous stem cells. Neurotherapeutics. 2011;8(4):650–658. doi:10.1007/s13311-011-0065-x21904791
   PubMed Web of Science ®Google Scholar
• Mozafari S, Sherafat MA, Javan M, Mirnajafi-Zadeh J, Tiraihi T. Visual evoked potentials and MBP gene expression imply endogenous myelin repair in adult rat optic nerve and chiasm following local lysolecithin induced demyelination. Brain Res. 2010;1351:50–56. doi:10.1016/j.brainres.2010.07.02620637745
   PubMed Web of Science ®Google Scholar
• Cruz-Martinez P, González-Granero S, Molina-Navarro M, et al. Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model. Cell Death Dis. 2016;7(5):e2223. doi:10.1038/cddis.2016.13027171265
   PubMed Web of Science ®Google Scholar
• Hao P, Liang Z, Piao H, et al. Conditioned medium of human adipose-derived mesenchymal stem cells mediates protection in neurons following glutamate excitotoxicity by regulating energy metabolism and GAP-43 expression. Metab Brain Dis. 2014;29(1):193–205. doi:10.1007/s11011-014-9490-y24458787
   PubMed Web of Science ®Google Scholar
• Yao C, Yang D, Wan Z, et al. Aspirin-triggered lipoxin A4 attenuates lipopolysaccharide induced inflammatory response in primary astrocytes. Int Immunopharmacol. 2014;18(1):85–89. doi:10.1016/j.intimp.2013.10.02824269179
   PubMed Web of Science ®Google Scholar
• Li Y, Gao X, Wang J. Human adipose-derived mesenchymal stem cell-conditioned media suppresses inflammatory bone loss in a lipopolysaccharide-induced murine model. Exp Ther Med. 2018;15(2):1839–1846. doi:10.3892/etm.2017.560629434773
   PubMed Web of Science ®Google Scholar
• Heidari M, Pouya S, Baghaei K, et al. The immunomodulatory effects of adipose-derived mesenchymal stem cells and mesenchymal stem cells‐conditioned medium in chronic colitis. J Cell Physiol. 2018;233(11):8754–8766. doi:10.1002/jcp.2676529797577
   PubMed Web of Science ®Google Scholar
• Sun H, Bénardais K, Stanslowsky N, et al. Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in amyotrophic lateral sclerosis (ALS)-in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia. PLoS One. 2013;8(9):e72926. doi:10.1371/journal.pone.007292624069165
   PubMed Web of Science ®Google Scholar
• Qie H, Fan S, Feng Z, Wang F, Hou X, Shan L. The inhibitory effect of mesenchymal stem cell conditioned medium on the secretion of inflammatory factor of human gingival fibroblast induced by lipopolysaccharide. Int J Clin Exp Med. 2018;11(6):5715–5721.
   Web of Science ®Google Scholar
• Pettit LK, Varsanyi C, Tadros J, Vassiliou E. Modulating the inflammatory properties of activated microglia with docosahexaenoic acid and aspirin. Lipids Health Dis. 2013;12(1):16. doi:10.1186/1476-511X-12-1623398903
   PubMed Web of Science ®Google Scholar
• Bae M-K, Kim S-R, Lee H-J, et al. Aspirin-induced blockade of NF-κB activity restrains up-regulation of glial fibrillary acidic protein in human astroglial cells. Biochim Et Biophys Acta (bba)-mol Cell Res. 2006;1763(3):282–289. doi:10.1016/j.bbamcr.2006.01.005
   Web of Science ®Google Scholar